Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Three-way crossover nerve excitability threshold tracking study in healthy male subjects
NL-OMON60146Phase 1Completed
- Sponsor
- Centre for Human Drug Research
- Start
- May 2024
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Placebo-COD Research Private Ltd in Neuralgia (3 arms), sponsored by Centre for Human Drug Research. Started May 2024; status: completed.
02
Drugs
Placebo-COD Research Private Ltd
03
Conditions
Neuralgia
Beyond the preview
Go deeper on NL-OMON60146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60146.